MedTrace Logo

To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves

NCT02022683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2019-07-02

No results posted yet for this study

Summary

To compare the clinical outcomes of Endoscopic Lung Volume Reduction (ELVR) using Pulmonx Zephyr Valves vs. Standard of Care (SoC) in the treatment of heterogeneous emphysema subjects in a controlled trial design setting.

Conditions

  • COPD
  • Heterogeneous Emphysema

Interventions

DEVICE

ELVR (Endoscopic Lung Volume Reduction) with Zephyr Valves

Sponsors & Collaborators

  • Pulmonx Corporation

    lead INDUSTRY

Principal Investigators

  • Gunnar Hillerdal, MD, PhD · Uppsala University Hospital, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-28
Primary Completion
2017-01-20
Completion
2018-09-27

Countries

  • Belgium
  • France
  • Germany
  • Netherlands
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022683 on ClinicalTrials.gov